Cargando…
Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population
BACKGROUND: The retinoid isomerohydrolase RPE65 has received considerable attention worldwide since a successful clinical gene therapy was approved in 2017 as the first treatment for vision loss associated with RPE65-mediated inherited retinal disease. Identifying patients with RPE65 mutations is a...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097799/ https://www.ncbi.nlm.nih.gov/pubmed/33952291 http://dx.doi.org/10.1186/s13023-021-01807-3 |
_version_ | 1783688386032173056 |
---|---|
author | Gao, Feng-Juan Wang, Dan-Dan Li, Jian-Kang Hu, Fang-Yuan Xu, Ping Chen, Fang Qi, Yu-He Liu, Wei Li, Wei Zhang, Sheng-Hai Chang, Qing Xu, Ge-Zhi Wu, Ji-Hong |
author_facet | Gao, Feng-Juan Wang, Dan-Dan Li, Jian-Kang Hu, Fang-Yuan Xu, Ping Chen, Fang Qi, Yu-He Liu, Wei Li, Wei Zhang, Sheng-Hai Chang, Qing Xu, Ge-Zhi Wu, Ji-Hong |
author_sort | Gao, Feng-Juan |
collection | PubMed |
description | BACKGROUND: The retinoid isomerohydrolase RPE65 has received considerable attention worldwide since a successful clinical gene therapy was approved in 2017 as the first treatment for vision loss associated with RPE65-mediated inherited retinal disease. Identifying patients with RPE65 mutations is a prerequisite to assessing the patients’ eligibility to receive RPE65-targeted gene therapies, and it is necessary to identify individuals who are most likely to benefit from gene therapies. This study aimed to investigate the RPE65 mutations frequency in the Chinese population and to determine the genetic and clinical characteristics of these patients. RESULTS: Only 20 patients with RPE65 mutations were identified, and RPE65 mutations were determined to be the 14th most common among all patients with genetic diagnoses. Ten novel variants and two hotspots associated with FAP were identified. A literature review revealed that a total of 57 patients of Chinese origin were identified with pathogenic mutations in the RPE65 gene. The mean best Snellen corrected visual acuity was worse (mean 1.3 ± 1.3 LogMAR) in patients older than 20 years old than in those younger than 15 years old (0.68 ± 0.92 LogMAR). Bone spicule-like pigment deposits (BSLPs) were observed in six patients; they were older than those without BSLP and those with white-yellow dots. Genotype–phenotype analysis revealed that truncating variants seem to lead to a more severe clinical presentation, while best corrected visual acuity testing and fundus changes did not correlate with specific RPE65 variants or mutation types. CONCLUSIONS: This study provides a detailed clinical-genetic assessment of patients with RPE65 mutations of Chinese origin. These results may help to elucidate RPE65 mutations in the Chinese population and may facilitate genetic counseling and the implementation of gene therapy in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01807-3. |
format | Online Article Text |
id | pubmed-8097799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80977992021-05-05 Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population Gao, Feng-Juan Wang, Dan-Dan Li, Jian-Kang Hu, Fang-Yuan Xu, Ping Chen, Fang Qi, Yu-He Liu, Wei Li, Wei Zhang, Sheng-Hai Chang, Qing Xu, Ge-Zhi Wu, Ji-Hong Orphanet J Rare Dis Research BACKGROUND: The retinoid isomerohydrolase RPE65 has received considerable attention worldwide since a successful clinical gene therapy was approved in 2017 as the first treatment for vision loss associated with RPE65-mediated inherited retinal disease. Identifying patients with RPE65 mutations is a prerequisite to assessing the patients’ eligibility to receive RPE65-targeted gene therapies, and it is necessary to identify individuals who are most likely to benefit from gene therapies. This study aimed to investigate the RPE65 mutations frequency in the Chinese population and to determine the genetic and clinical characteristics of these patients. RESULTS: Only 20 patients with RPE65 mutations were identified, and RPE65 mutations were determined to be the 14th most common among all patients with genetic diagnoses. Ten novel variants and two hotspots associated with FAP were identified. A literature review revealed that a total of 57 patients of Chinese origin were identified with pathogenic mutations in the RPE65 gene. The mean best Snellen corrected visual acuity was worse (mean 1.3 ± 1.3 LogMAR) in patients older than 20 years old than in those younger than 15 years old (0.68 ± 0.92 LogMAR). Bone spicule-like pigment deposits (BSLPs) were observed in six patients; they were older than those without BSLP and those with white-yellow dots. Genotype–phenotype analysis revealed that truncating variants seem to lead to a more severe clinical presentation, while best corrected visual acuity testing and fundus changes did not correlate with specific RPE65 variants or mutation types. CONCLUSIONS: This study provides a detailed clinical-genetic assessment of patients with RPE65 mutations of Chinese origin. These results may help to elucidate RPE65 mutations in the Chinese population and may facilitate genetic counseling and the implementation of gene therapy in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01807-3. BioMed Central 2021-04-13 /pmc/articles/PMC8097799/ /pubmed/33952291 http://dx.doi.org/10.1186/s13023-021-01807-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Gao, Feng-Juan Wang, Dan-Dan Li, Jian-Kang Hu, Fang-Yuan Xu, Ping Chen, Fang Qi, Yu-He Liu, Wei Li, Wei Zhang, Sheng-Hai Chang, Qing Xu, Ge-Zhi Wu, Ji-Hong Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population |
title | Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population |
title_full | Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population |
title_fullStr | Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population |
title_full_unstemmed | Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population |
title_short | Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population |
title_sort | frequency and phenotypic characteristics of rpe65 mutations in the chinese population |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097799/ https://www.ncbi.nlm.nih.gov/pubmed/33952291 http://dx.doi.org/10.1186/s13023-021-01807-3 |
work_keys_str_mv | AT gaofengjuan frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT wangdandan frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT lijiankang frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT hufangyuan frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT xuping frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT chenfang frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT qiyuhe frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT liuwei frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT liwei frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT zhangshenghai frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT changqing frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT xugezhi frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation AT wujihong frequencyandphenotypiccharacteristicsofrpe65mutationsinthechinesepopulation |